Company research / RCEL

AVITA Medical, Inc. (RCEL)

Also trades as AVHHL. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

CIK 0001762303 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, AVITA Medical, Inc. reported revenue of $71.61M. Revenue grew 11.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $75.63M.

Key ratios (year ended 2025-12-31)

82.1%
Gross margin
-59.4%
Operating margin
-67.8%
Net margin
11.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4/A (ownership change) · 2026-08-24

Headquarters locality: Perth · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312021-06-302020-06-302019-06-302018-06-30
Revenue$75.63M$71.61M$64.25M$50.14M$34.42Mn/a$29.23M$14.26M$5.47M$929.0K
Cost of Revenue$13.95M$12.79M$9.09M$7.78M$6.04Mn/a$5.95M$2.97M$1.27M$546.0K
Gross Profit$61.68M$58.82M$55.16M$42.36M$28.38Mn/a$23.28M$11.29M$4.20M$383.0K
R&D Expense$20.15M$20.84M$20.36M$20.82M$13.86Mn/a$14.82M$9.16M$8.00M$6.26M
Operating Income-$35.22M-$42.53M-$56.59M-$42.66M-$27.50Mn/a-$26.54M-$42.68M-$25.53M-$13.84M
Depreciation & Amortization$2.51M$2.35M$1.13M$632.0K$568.0Kn/a$715.0K$465.0K$269.0K$110.0K
EBITDA-$32.71M-$40.19M-$55.47M-$42.02M-$26.94Mn/a-$25.82M-$42.21M-$25.26M-$13.73M
Net Income-$43.08M-$48.59M-$61.84M-$35.38M-$26.66Mn/a-$26.58M-$42.03M-$25.10M-$12.73M
EPS (Diluted)n/a-$1.74-$2.39-$1.40$1.07n/a$1.17$2.07$1.56$1.37
Total Assets$47.78M$56.39M$79.71M$111.64M$98.26M$116.02M$125.50M$82.46M$25.78Mn/a
Total Liabilities$75.61M$73.04M$74.97M$61.89M$12.97M$11.39M$9.85M$10.06M$4.95Mn/a
Shareholders' Equity-$27.84M-$16.65M$4.50M$49.06M$84.74M$104.62M$115.66M$72.40M$20.83M$14.03M
Cash & Equivalents$9.14M$10.24M$14.05M$22.12M$18.16M$55.51M$110.75M$73.64M$20.17Mn/a
Operating Cash Flow-$24.23M-$31.20M-$48.94M-$38.01M-$19.09Mn/a-$25.90M-$22.75M-$19.25M-$12.96M
Capital Expenditures$387.0K$1.00M$9.17M$1.38M$452.0Kn/a$894.0K$590.0K$1.02M$365.0K
Free Cash Flow-$24.61M-$32.20M-$58.11M-$39.39M-$19.54Mn/a-$26.80M-$23.34M-$20.27M-$13.32M
Shares Outstanding30.93M30.57M26.35M25.68M25.21M24.93M24.90M21.47M18.71Mn/a
Weighted Average Diluted Sharesn/a27.86M25.88M25.33M25.00Mn/a22.67M20.29M16.06M9.33M
EPS (Basic)n/a-$1.74-$2.39-$1.40$1.07n/a$1.17$2.07$1.56$1.37

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView